Logo
Unionpedia
Communication
Get it on Google Play
New! Download Unionpedia on your Android™ device!
Free
Faster access than browser!
 

Aripiprazole and Mesolimbic pathway

Shortcuts: Differences, Similarities, Jaccard Similarity Coefficient, References.

Difference between Aripiprazole and Mesolimbic pathway

Aripiprazole vs. Mesolimbic pathway

Aripiprazole, sold under the brand name Abilify among others, is an atypical antipsychotic. It is recommended and primarily used in the treatment of schizophrenia and bipolar disorder. Other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. According to a Cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. Additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low. Side effects include neuroleptic malignant syndrome, a movement disorder known as tardive dyskinesia, and high blood sugar in those with diabetes. In the elderly there is an increased risk of death. It is thus not recommended for use in those with psychosis due to dementia. It is pregnancy category C in the United States and category C in Australia, meaning there is possible evidence of harm to the fetus. It is not recommended for women who are breastfeeding. It is unclear whether it is safe or effective in people less than 18 years old. It is a partial dopamine agonist. Aripiprazole was developed by Otsuka in Japan. In the United States, Otsuka America markets it jointly with Bristol-Myers Squibb. From April 2013 to March 2014, sales of Abilify amounted to almost $6.9 billion. The mesolimbic pathway, sometimes referred to as the reward pathway, is a dopaminergic pathway in the brain.

Similarities between Aripiprazole and Mesolimbic pathway

Aripiprazole and Mesolimbic pathway have 4 things in common (in Unionpedia): Major depressive disorder, Mesocortical pathway, Schizophrenia, Striatum.

Major depressive disorder

Major depressive disorder (MDD), also known simply as depression, is a mental disorder characterized by at least two weeks of low mood that is present across most situations.

Aripiprazole and Major depressive disorder · Major depressive disorder and Mesolimbic pathway · See more »

Mesocortical pathway

The mesocortical pathway is a dopaminergic pathway that connects the ventral tegmentum to the prefrontal cortex.

Aripiprazole and Mesocortical pathway · Mesocortical pathway and Mesolimbic pathway · See more »

Schizophrenia

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality.

Aripiprazole and Schizophrenia · Mesolimbic pathway and Schizophrenia · See more »

Striatum

The striatum, or corpus striatum (also called the neostriatum and the striate nucleus) is a nucleus (a cluster of neurons) in the subcortical basal ganglia of the forebrain.

Aripiprazole and Striatum · Mesolimbic pathway and Striatum · See more »

The list above answers the following questions

Aripiprazole and Mesolimbic pathway Comparison

Aripiprazole has 146 relations, while Mesolimbic pathway has 34. As they have in common 4, the Jaccard index is 2.22% = 4 / (146 + 34).

References

This article shows the relationship between Aripiprazole and Mesolimbic pathway. To access each article from which the information was extracted, please visit:

Hey! We are on Facebook now! »